Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

1RT Acquisition Corp.

CIK: 20542721 Annual ReportLatest: 2026-03-27

10-K / March 27, 2026

Blank-Check Company

What the company is

  • A blank-check (SPAC) company incorporated in the Cayman Islands on December 13, 2024.
  • Formed to effect a single initial Business Combination (a merger, acquisition, or similar transaction) with one or more target businesses or entities.
  • As of the report date, no target had been selected.

Operational status

  • No operating revenues to date.
  • No customers have been identified or served; the plan is to pursue a Business Combination rather than operate a current business.
  • Two officers on the management team: Tapiero and Majocha.
  • No full-time employees prior to completing an initial Business Combination.

IPO and fundraising

  • On July 3, 2025, completed an Initial Public Offering (IPO) of 17,250,000 Units, including 2,250,000 Over-Allotment Option Units.
  • Each Unit consisted of one Public Share and one-quarter of one Public Warrant; each full Public Warrant permits purchase of one Class A Ordinary Share at $11.50.
  • IPO price: $10.00 per Unit.
  • Gross proceeds from the IPO: $172,500,000.
  • Simultaneously, 2,250,000 Private Placement Warrants were sold at $2.00 each, generating $4,500,000 in gross proceeds.
  • Sponsor purchased 1,500,000 of the Private Placement Warrants; Cantor purchased 750,000.
  • A total of $172,500,000 (IPO proceeds plus Private Placement proceeds) was placed in the Trust Account.

Use of funds and Trust Account

  • The Trust Account holds funds intended to finance the initial Business Combination and related redemptions.
  • As of December 31, 2025, the Trust Account balance was approximately $172.5 million less a Deferred Fee.
  • After payment of $8,212,500 of the Deferred Fee, cash available for a Business Combination was $164,287,500.
  • Per-share redemption value (as of that date) was approximately $10.20 per Public Share (before taxes).
  • Cash and liquidity outside the Trust Account to fund ongoing operations: approximately $383,075 as of December 31, 2025.

Business strategy and target criteria

  • Focus area: digital assets and blockchain sectors, based on the senior leadership and advisory experience of the sponsor and management team (including affiliates of 50T).
  • Target guidelines (not exclusive): enterprise value greater than $1.0 billion (transactions outside this range may be considered); emphasis on industry leadership, access to public markets, strong leadership, and proven business models.
  • The company may pursue targets outside these guidelines and will disclose material deviations in shareholder communications related to the Business Combination.

Acquisition process and structure

  • Expectation of a due diligence process including meetings with management, document reviews, and financial, legal, and operational assessment.
  • Transactions may involve cash, stock, debt, or a combination. The post-transaction company is expected to have Public Shareholders owning 50% or more of the equity or otherwise hold a controlling interest.
  • If a Business Combination involves affiliated parties, an independent valuation opinion may be sought.
  • No current mandate to use professional finders, though finder fees or engagements could occur if determined beneficial.

Redemptions and governance mechanics

  • Public Shareholders will have the right to redeem their Class A Ordinary Shares for a pro rata cash share of the Trust Account either at the time of a general vote on the Business Combination or via a tender offer, depending on the chosen process.
  • The company intends to provide redemption rights for Public Shares; for certain charter amendments (e.g., extending the Combination Period or altering redemption rights), the redemption mechanism applies as described in the charter.
  • Sponsor and certain insiders have agreed to vote in favor of the Business Combination and have waived redemption rights on Founder Shares.
  • There is a 24-month Combination Period from the closing of the IPO to consummate a Business Combination, with potential extensions by charter amendment subject to shareholder approval and applicable redemption options.

Capital structure and dilution considerations

  • Authorized capital: up to 200,000,000 Class A Ordinary Shares, 20,000,000 Class B Ordinary Shares, and 1,000,000 preference shares.
  • Founder Shares: 4,312,500 issued to Sponsor (approximately $25,000 paid); Sponsor holds 20% of issued and outstanding ordinary shares.
  • Public Shares: 17,250,000 issued in the IPO.
  • Private Placement Warrants: 2,250,000; exercisable at $11.50.
  • Anti-dilution protections for Founder Shares (and for Class B conversions) may cause dilution to Public Shareholders upon consummation of a Business Combination.
  • Sponsor and Cantor hold Private Placement Warrants; those holders have registration and other rights that could affect the post-transaction capital structure.

Management and control

  • Sponsor and its affiliates have substantial influence. Sponsor owns 20% of the issued and outstanding ordinary shares and will appoint directors prior to completion of the initial Business Combination.
  • The board is classified with staggered terms; director appointments prior to the Business Combination are controlled by the Sponsor through Founder Shares.
  • No working employees beyond the two officers prior to the Business Combination.

Compliance, regulatory and jurisdictional notes

  • Subject to Nasdaq listing requirements and 2024 SPAC rules, which may affect costs and timing to complete a Business Combination.
  • Operates as an emerging growth company and a smaller reporting company, with certain reduced disclosure obligations.
  • Organized as a Cayman Islands exempted company; shareholder rights and dispute resolution may differ under Cayman law. The charter and warrant agreements include exclusive forum provisions.

Financial snapshot

  • Proceeds in the Trust Account at closing: $172.5 million (net of a Deferred Underwriter Fee of $8,212,500 paid by December 31, 2025).
  • Cash available for a Business Combination (as of December 31, 2025): $164,287,500.
  • Public redemption value (as of December 31, 2025): approximately $10.20 per Public Share.
  • Cash outside the Trust Account (working capital): approximately $383,075 as of December 31, 2025.
  • No operating revenues or profits to date; no customers; founders and insiders hold a significant stake and have agreed to vote in favor of the Business Combination.